A Study of BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

NCT06405425 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Urothelial Carcinoma

Interventions

DRUG: BL-B01D1
DRUG: PD-1

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]